Indeed, a better understanding of the anti-inflammatory nature of estrogen receptors and their role in regulating the expression of inflammation-related molecules by breast cancer cells may help us identify novel molecular targets and personalized therapeutic options. Here, ESR1 is linked to breast carcinoma.